Filtered By:
Countries: Egypt Health
This page shows you your search results in order of relevance. This is page number 5.
Order by Relevance | Date
Total 106 results found since Jan 2013.
Aspirin resistance: Prevalence and clinical outcome in Egypt
Publication date: Available online 7 January 2015 Source:The Egyptian Journal of Critical Care Medicine Author(s): Ahmed Salah , Mohammed El-Desuky , Amal Rizk , Amr El-Hadidy Introduction The antiplatelet drug aspirin is considered as a cornerstone in medical treatment of patients with CV or cerebrovascular diseases. Despite its use, a significant number of patients had recurrent adverse ischemic events. Inter-individual variability of platelet aggregation in response to aspirin may be an explanation for some of these events. Multiple trials have linked aspirin resistance to these adverse events. Objectives The aim of ...
Source: The Egyptian Journal of Critical Care Medicine - January 8, 2015 Category: Intensive Care Source Type: research
Clinical characteristics and management of hospitalized and ambulatory patients with heart failure–results from ESC heart failure long‐term registry–Egyptian cohort
ConclusionPatients in the Egyptian cohort exhibited distinct features from HF patients in other countries in the ESC‐HF Long‐term Registry.
Source: ESC Heart Failure - June 1, 2015 Category: Cardiology Authors: Mahmoud Hassanein, Magdy Abdelhamid, Bassem Ibrahim, Ahmed Elshazly, Mohamed Wafaie Aboleineen, Hesham Sobhy, Gamela Nasr, Fatma Elmesseiry, Ahmed Abdelmoniem, Medhat Ashmawy, Nabil Farag, Amr Youssef, Atef Elbahry, Yahia Elrakshy, Mohamed Sobhy, Tarek M. Tags: Original Research Article Source Type: research
Takotsubu syndrome in a patient with acute ischemic stroke: Case report
Publication date: Available online 4 September 2017 Source:The Egyptian Journal of Critical Care Medicine Author(s): H. Akram, N. Chatterjee, N. Suri, M. Saad, N Yakoub, H. Awadallah
Source: The Egyptian Journal of Critical Care Medicine - September 5, 2017 Category: Intensive Care Source Type: research
Impact of elevated glycosylated hemoglobin on hospital outcome and 1 year survival of primary isolated coronary artery bypass grafting patients
Conclusions This study showed that HbA1c is a good predictor of in-hospital morbidity. It worth devoting time and effort to decrease HbA1c level below 7% to decrease possible postoperative complications.
Source: The Egyptian Heart Journal - October 28, 2017 Category: Cardiology Source Type: research
Stroke burden in Egypt: data from five epidemiological studies
.
Source: International Journal of Neuroscience - January 5, 2018 Category: Neuroscience Authors: Foad Abd-Allah Eman Khedr Mohammed I Oraby Ahmed Safwat Bedair Shady Samy Georgy Ramez Reda Moustafa Source Type: research
The relation between nonalcoholic fatty liver disease and carotid intima-media thickness in Egyptian patients
This study was designed to assess the correlation between NAFLD as a cardiovascular risk factor and carotid atherosclerosis.
Patients and methods
A hospital-based case–control analytical study was conducted on 60 participants who were divided into three groups as follows. Group I included 20 diabetic patients with NAFLD. Group II included 20 nondiabetic patients with NAFLD. Group III included 20 healthy participants who served as a control group. The right and left carotid intima-media thickness (CIMTs) and their maximum reading (CIMTmax) was measured by a skilled sonographer blind to the groups. Pelviabdominal ultras...
Source: Egyptian Liver Journal - January 1, 2017 Category: Gastroenterology Tags: Original articles Source Type: research
Primary PCI versus Pharmaco-Invasive Strategy in Patients with ST-Elevation Myocardial Infarction; a Randomized Clinical Study
Conclusion: Immediate fibrinolysis followed by coronary angiography 3-24 hr later resulted in similar short term outcome and earlier effective reperfusion in patients with STEMI compared to PPCI.Keywords:Fibrinolysis,PCI,Reperfusion,STEMIView:PDF (323.13 KB)Click here to download the PDF file.‹ Probability of Dying and Survival Analysis of Diabetic and/Hypertensive Patients Who Undergone Hemodialysis with Heart Disease Complication: A Comparison between a Hemodialysis Center Jakarta, Indonesia and Penang, MalaysiaAssessment of Risk Factors for the Cardiovascular Diseases in People Visiting a Tertiary Care Hospital for Ro...
Source: Journal of Cardiovascular Disease Research - March 8, 2018 Category: Cardiology Authors: yunus Source Type: research
Genetic study of the NOTCH3 gene in CADASIL patients
Conclusion We found four novel mutations (P109T, P203H, IVS7 + 15A>G and IVS7 + 16A>G) and 2 reported NOTCH3 mutations. Exon 4 and Intron 7 are hotspots in the patients we examined with the NOTCH3 mutations. These findings broaden the mutational spectrum of CADASIL.
Source: Egyptian Journal of Medical Human Genetics - May 24, 2018 Category: Genetics & Stem Cells Source Type: research
World No Tobacco Day 2018: Tobacco breaks hearts
Cairo, Egypt, 31 May – Every year, on 31 May, the World Health Organization (WHO) and partners mark World No Tobacco Day, highlighting the health and other risks associated with tobacco use, and advocating for effective policies to reduce tobacco consumption. This year, World No Tobacco Day focuses on tobacco and heart disease. The campaign’s slogan is “Tobacco breaks hearts. Choose health, not tobacco”.
Tobacco use is one of the leading causes of premature death and disability worldwide. It is also a key risk factor for the development of coronary heart disease, stroke and peripheral vascular disease. “In most ...
Source: WHO EMRO News - May 26, 2018 Category: Middle East Health Source Type: news
Clinical safety profile of ticagrelor compared to clopidogrel in 1208 patients: Real world evidence
Conclusion In the real world settings, patients undergoing PCI treated with ticagrelor showed similar safety profile compared to clopidogrel but with increase in minor bleeding rate. The observed results were in alignment with PLATO clinical trial.
Source: The Egyptian Heart Journal - June 14, 2018 Category: Cardiology Source Type: research
New funding to UC Riverside to significantly boost cancer, ALS research
(University of California - Riverside) Maurizio Pellecchia at the University of California, Riverside has received two grants to continue his research aimed at finding therapeutics for cancer, amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases. The first grant from the US-Egypt Science and Technology Joint Fund of the National Academy of Sciences, Engineering, and Medicine totals $190,000 for two years. The second is a nearly $2.3 million, five-year grant from the National Institute of Neurological Disorders and Stroke.
Source: EurekAlert! - Cancer - June 21, 2018 Category: Cancer & Oncology Source Type: news
Clinical safety profile of ticagrelor compared to clopidogrel in 1208 patients: Real world evidence
ConclusionIn the real world settings, patients undergoing PCI treated with ticagrelor showed similar safety profile compared to clopidogrel but with increase in minor bleeding rate. The observed results were in alignment with PLATO clinical trial.
Source: The Egyptian Heart Journal - July 5, 2018 Category: Cardiology Source Type: research
Impact of elevated glycosylated hemoglobin on hospital outcome and 1 year survival of primary isolated coronary artery bypass grafting patients
ConclusionsThis study showed that HbA1c is a good predictor of in-hospital morbidity. It worth devoting time and effort to decrease HbA1c level below 7% to decrease possible postoperative complications.
Source: The Egyptian Heart Journal - July 5, 2018 Category: Cardiology Source Type: research
Subclinical myocardial dysfunction by tissue Doppler echocardiography in primary antiphospholipid syndrome: Preliminary results
ConclusionThe present study demonstrated subclinical myocardial dysfunction using TDI in asymptomatic PAPS patients. TDI is non-invasive and cost effective. Prospective studies including a large number of participants in order to confirm these preliminary data are needed.
Source: The Egyptian Rheumatologist - July 5, 2018 Category: Rheumatology Source Type: research
Genetic study of the NOTCH3 gene in CADASIL patients
ConclusionWe found four novel mutations (P109T, P203H, IVS7 + 15A>G and IVS7 + 16A>G) and 2 reported NOTCH3 mutations. Exon 4 and Intron 7 are hotspots in the patients we examined with the NOTCH3 mutations. These findings broaden the mutational spectrum of CADASIL.
Source: Egyptian Journal of Medical Human Genetics - July 5, 2018 Category: Genetics & Stem Cells Source Type: research
